Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Total Company Q4 and Full Year Financial Results from Continuing Operations
STE logo

STERIS Achieves $5.9 Billion in Annual Revenue with 10% Adjusted EPS Growth

STE8-KFiling Date: 5/11/2026
STERIS plc
Description

What this story covers

STERIS plc's fiscal 2026 saw 8.7% revenue growth and strong segment performance. Analysts discussed operational cash flow and optimistic 2027 guidance, driven by recurring revenue and strategic investments like a new Ohio plant.

Story snapshot

CompanySTERIS plc
TickerSTE
VariantStandard detailed
Duration5:11
Filing type8-K
PeriodAnnual 2026
IndustryHealthcare & Pharmaceuticals
Accession0001628280-26-033580
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing8-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in